De Nicola, Luca http://orcid.org/0000-0001-8532-0182
Ferraro, Pietro Manuel http://orcid.org/0000-0002-1379-022X
Montagnani, Andrea http://orcid.org/0000-0001-7636-2700
Pontremoli, Roberto http://orcid.org/0000-0003-1238-872X
Dentali, Francesco http://orcid.org/0000-0003-4195-7725
Sesti, Giorgio http://orcid.org/0000-0002-1618-7688
Funding for this research was provided by:
AstraZeneca
UniversitĂ Cattolica del Sacro Cuore
Article History
Received: 30 May 2023
Accepted: 4 September 2023
First Online: 29 September 2023
Declarations
:
: Luca De Nicola has received consultancy or lecture fees from Astellas, AstraZeneca, Novo Nordisk, and CSL Vifor. Pietro Manuel Ferraro has received research grants, consultancy fees, or other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, BioHealth Italia, Gilead, Otsuka Pharmaceuticals, Rocchetta, and CSL Vifor; and royalties as an author from UpToDate. Andrea Montagnani has received consultancy or lecture fees from BMS, Pfizer, Bayer, Boehringer Ingelheim, AstraZeneca, and CSL Vifor. Roberto Pontremoli has received consultancy or lecture fees from AstraZeneca, Boehringer Ingelheim, Lilly, MSD, Novartis, Menarini, Bayer, Recordati International, Alfasigma, Novo Nordisk, and CSL Vifor. Giorgio Sesti has received speaker fees from Novo Nordisk, Eli Lilly, AstraZeneca, Teva, MSD, Sanofi, Daiichi Sankyo, Sobi, Janssen, and Servier. Francesco Dentali declares no conflicts of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: Not applicable.